 | Up a level |
van den Bent, Martin J; Baumert, Brigitta; Erridge, Sara C; Vogelbaum, Michael A; Nowak, Anna K; Sanson, Marc; Brandes, Alba Ariela; Clement, Paul M; Baurain, Jean Francais; Mason, Warren P; Wheeler, Helen; Chinot, Olivier L; Gill, Sanjeev; Griffin, Matthew; Brachman, David G; Taal, Walter; Rudà, Roberta; Weller, Michael; McBain, Catherine; Reijneveld, Jaap; ... (2017). Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. Lancet, 390(10103), pp. 1645-1653. Elsevier 10.1016/S0140-6736(17)31442-3
Seliger, Corinna; Ricci, Cristian; Meier, Christoph R; Bodmer, Michael; Jick, Susan S; Bogdahn, Ulrich; Hau, Peter; Leitzmann, Michael F (2015). Diabetes, use of antidiabetic drugs, and the risk of glioma. Neuro-Oncology, 18(3), pp. 340-349. Oxford University Press 10.1093/neuonc/nov100
